SOPHARMA AD - Current report 91 Lavena AD above 5% (91/2013)
SOPHARMA AD - Current report 91 Lavena AD above 5% (91/2013)
POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
UNI - EN REPORT No | 91 | / | 2013 | ||||||||
Date of issue: | 2013-07-04 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
Current report 91 Lavena AD above 5% | |||||||||||
Official market - legal basis | |||||||||||
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
Sopharma AD (the ?Company") announces that on 18 June 2013 the Company bought 4 039 from the capital increase of Lavena AD. After this transaction, the share of Sopharma AD in the capital of Lavena AD increased to 5.18%. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
Current report 91 Lavena AD above 5%.doc | Current report 91 Lavena AD above 5% |
REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
| | | SOPHARMA AD | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | (fullname of the issuer) | | | | | |
| | | SOPHARMA AD | | Farmaceutyczny (far) | | | |
| | | (short name of the issuer) | | (sector according to clasification of the WSE in Warsow) | | | |
| | | 1220 | | Sofia | | | |
| | | (post code) | | (city) | | | |
| | | IlienskoShosse | | 16 | | | |
| | | (street) | | (number) | | | |
| | | +359 2 813 42 00 | | +359 2 936 02 86 | | | |
| | | (phone number) | | | (fax) | | |
| | | (e-mail) | | | (web site) | | |
| | | nd | | | | | |
| | | (NIP)
| | | (REGON) | | |
REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
---|---|---|---|---|---|
Date | Name | Position / Function | Signature | ||
2013-07-04 | Ognian Donev | Executive Director |
REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY